SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-20-007143
Filing Date
2020-01-27
Accepted
2020-01-27 16:23:56
Documents
2
Group Members
ARTHUR COHENHEALTHCOR ASSOCIATES, LLCHEALTHCOR GROUP, LLCHEALTHCOR MARKET NEUTRAL GP, LLCHEALTHCOR MARKET NEUTRAL MASTER FUND, L.P.HEALTHCOR OFFSHORE GP, LLCHEALTHCOR OFFSHORE II GP, LLCHEALTHCOR OFFSHORE MASTER FUND, L.P.HEALTHCOR SANATATE OFFSHORE MASTE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tv537160_sc13g.htm SC 13G 128993
2 EXHIBIT 1 tv537160_ex1.htm EX-99.1 10841
  Complete submission text file 0001104659-20-007143.txt   141750
Mailing Address 55 HUDSON YARDS, 28TH FLOOR NEW YORK NY 10001
Business Address 55 HUDSON YARDS, 28TH FLOOR NEW YORK NY 10001 212-622-7731
HealthCor Management, L.P. (Filed by) CIK: 0001343781 (see all company filings)

IRS No.: 202893581 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Subject) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88628 | Film No.: 20549799
SIC: 2834 Pharmaceutical Preparations